• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Sarsynski Elaine A was granted 41,622 shares, increasing direct ownership by 46% to 132,899 units (SEC Form 4)

    5/23/25 4:23:47 PM ET
    $GNW
    Life Insurance
    Finance
    Get the next $GNW alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sarsynski Elaine A

    (Last) (First) (Middle)
    C/O GENWORTH FINANCIAL, INC.
    11011 WEST BROAD STREET

    (Street)
    GLEN ALLEN VA 23060

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    GENWORTH FINANCIAL INC [ GNW ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/22/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/22/2025 A 41,621.816(1) A $6.9675(2) 132,899.154 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Reflects award of restricted stock units (RSUs) in payment of a portion of the reporting person's annual retainer fee. The RSUs vest on the one-year anniversary of the grant date, and convert to shares of Common Stock upon vesting (unless the reporting person elected to defer receipt of the shares until termination of service as a director or to a future specified year).
    2. Reflects the twenty-day average trading price per share of Common Stock, which was used to determine the number of RSUs granted.
    /s/ David F. Kurzawa, by power of attorney 05/23/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GNW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNW

    DatePrice TargetRatingAnalyst
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    More analyst ratings

    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Genworth Financial upgraded by Keefe Bruyette with a new price target

      Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

      6/18/25 7:44:47 AM ET
      $GNW
      Life Insurance
      Finance

    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Genworth Financial Schedules Earnings Conference Call for May 1

      Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing first quarter results after the market closes on April 30, 2025. A conference call will be held on May 1, 2025, at 10:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's May 1 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #3161071. To participate in the call by

      4/10/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance